Australia markets closed

Unity Biotechnology, Inc. (UBX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.50000.0000 (0.00%)
At close: 04:00PM EDT
1.5100 +0.01 (+0.67%)
After hours: 07:37PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 25.18M
Enterprise value 3.67M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)6.54
Price/book (mrq)0.70
Enterprise value/revenue 29.79
Enterprise value/EBITDA -0.08

Trading information

Stock price history

Beta (5Y monthly) 0.88
52-week change 3-63.59%
S&P500 52-week change 328.64%
52-week high 34.3700
52-week low 31.4610
50-day moving average 31.7479
200-day moving average 32.2199

Share statistics

Avg vol (3-month) 3112.2k
Avg vol (10-day) 3119.69k
Shares outstanding 516.79M
Implied shares outstanding 616.79M
Float 812.64M
% held by insiders 11.13%
% held by institutions 128.35%
Shares short (29 Feb 2024) 4290.64k
Short ratio (29 Feb 2024) 42.83
Short % of float (29 Feb 2024) 41.75%
Short % of shares outstanding (29 Feb 2024) 41.73%
Shares short (prior month 31 Jan 2024) 4306.12k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:10
Last split date 320 Oct 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 Sept 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-27.27%
Return on equity (ttm)-91.54%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -43.5M
Net income avi to common (ttm)-52.53M
Diluted EPS (ttm)-3.2000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)45.94M
Total cash per share (mrq)3.14
Total debt (mrq)27.79M
Total debt/equity (mrq)76.76%
Current ratio (mrq)5.74
Book value per share (mrq)2.48

Cash flow statement

Operating cash flow (ttm)-39.88M
Levered free cash flow (ttm)-20.42M